Singapore markets close in 2 hours 22 minutes
Straits Times Index
3,433.99 +18.48 (+0.54%) Nikkei
40,913.65 +332.89 (+0.82%) Hang Seng
18,004.67 +26.10 (+0.15%) FTSE 100
8,171.12 +49.92 (+0.61%) Bitcoin USD
58,813.76 -2,236.70 (-3.66%) CMC Crypto 200
1,230.69 -30.50 (-2.42%)
Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
As of 02:23PM CST. Market open.
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 6.72B |
| Enterprise value | 5.88B |
| Trailing P/E | 14.83 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.42 |
| Price/book (mrq) | 1.37 |
| Enterprise value/revenue | 0.38 |
| Enterprise value/EBITDA | 7.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.11 |
| 52-week change 3 | -16.82% |
| S&P500 52-week change 3 | 25.51% |
| 52-week high 3 | 3.9000 |
| 52-week low 3 | 2.4100 |
| 50-day moving average 3 | 2.8926 |
| 200-day moving average 3 | 3.1655 |
Share statistics
| Avg vol (3-month) 3 | 29.53M |
| Avg vol (10-day) 3 | 24.58M |
| Shares outstanding 5 | 2.52B |
| Implied shares outstanding 6 | 2.52B |
| Float 8 | 1.29B |
| % held by insiders 1 | 51.59% |
| % held by institutions 1 | 2.18% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 0.98 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 04 May 2018 |
| Last split factor 2 | 13:10 |
| Last split date 3 | 06 Apr 2016 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 2.87% |
| Operating margin (ttm) | 5.44% |
Management effectiveness
| Return on assets (ttm) | 2.93% |
| Return on equity (ttm) | 9.80% |
Income statement
| Revenue (ttm) | 15.67B |
| Revenue per share (ttm) | 6.29 |
| Quarterly revenue growth (yoy) | 5.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 891.23M |
| Net income avi to common (ttm) | 449.71M |
| Diluted EPS (ttm) | 0.1800 |
| Quarterly earnings growth (yoy) | 44.50% |
Balance sheet
| Total cash (mrq) | 2.85B |
| Total cash per share (mrq) | 1.13 |
| Total debt (mrq) | 2B |
| Total debt/equity (mrq) | 35.64% |
| Current ratio (mrq) | 1.29 |
| Book value per share (mrq) | 1.94 |
Cash flow statement
| Operating cash flow (ttm) | 496.25M |
| Levered free cash flow (ttm) | 430.21M |
© 2024 Yahoo. All rights reserved.